Delivery Order SPE2DB20D3104-SPE2DB21FV8H4
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, medical devices, and other critical care materials. This delivery order, valued at $4,499.78,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract deliverables include specialty medications,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials, to support military treatment facilities, veterans'...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The delivery order, valued at $2,408.70, is for the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award covers a wide variety of...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under DLA's Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, covers the supply of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This IDC serves as the...
- This award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items to support military healthcare programs...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver essential medical commodities, including specialty medications,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The delivery order, valued at $40,996.80, is for the provision of various pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract encompasses a wide range of critical...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV8H4Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through December 2025, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The current delivery order, valued at $1,431.74, covers the provision of various pharmaceutical and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to DoD and Veterans Affairs (VA) healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/21/21 |